Position | Company | Period |
---|
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
12 805
-40.2%
0,678 618 USD |
12 805 -40.2% | 0,67 | 8 618 USD | |
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 309
-40.5%
0,673 573 USD |
5 309 -40.5% | 0,67 | 3 573 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 220
-39.9%
0,854 458 USD |
5 220 -39.9% | 0,85 | 4 458 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 009
-39.6%
0,843 354 USD |
4 009 -39.6% | 0,84 | 3 354 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 440
-37.9%
1,868 250 USD |
4 440 -37.9% | 1,86 | 8 250 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 100
-38.9%
1,691 863 USD |
1 100 -38.9% | 1,69 | 1 863 USD | |
2022-08-01 | 2022-08-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 983
-38.2%
1,775 290 USD |
2 983 -38.2% | 1,77 | 5 290 USD | |
2022-07-05 | 2022-07-05 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 973
-38.9%
1,683 311 USD |
1 973 -38.9% | 1,68 | 3 311 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 368
-37.3%
3,1913 942 USD |
4 368 -37.3% | 3,19 | 13 942 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 076
-38.1%
3,543 813 USD |
1 076 -38.1% | 3,54 | 3 813 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
3 770
-37.3%
3,5613 409 USD |
3 770 -37.3% | 3,56 | 13 409 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 070
-37.9%
4,064 349 USD |
1 070 -37.9% | 4,06 | 4 349 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 358
-37.2%
5,6724 708 USD |
4 358 -37.2% | 5,67 | 24 708 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 058
-37.5%
6,156 509 USD |
1 058 -37.5% | 6,15 | 6 509 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 065
-37.7%
5,335 674 USD |
1 065 -37.7% | 5,33 | 5 674 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 823
-37.4%
9,2544 613 USD |
4 823 -37.4% | 9,25 | 44 613 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 144
-40.5%
5,135 874 USD |
1 144 -40.5% | 5,13 | 5 874 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
1 148
-40.6%
1,201 378 USD |
1 148 -40.6% | 1,20 | 1 378 USD |